Table 1 Characteristics of included studies
Author, year, country | Surgery | Goal-directed therapy (tools and goals) | Modality of optimization |
|---|---|---|---|
Ackland et al. [19] 2015, Europe | Major elective abdominal surgery | Lidco plus; SV < 10%, DO2 > 600 L∙min−1∙m−2 | Fluids and inotropes |
Arslan-Carlon et al. [20] 2020, USA | Open radical cystecctomy | FloTrac/Vigileo; SV < 10% CI ≥ 2.5 L min−1 m−2 | Fluids |
Bahlmann et al. [21] 2019, Europe | Tranthoracic eophageal resection | FloTrac/Vigileo; SV < 10% CI ≥ 2.5 L min−1 m−2 | Fluids and inotropes |
Bartha et al. [22] 2018, Europe | Orthopaedic | Lidco; SV < 10%, DO2 > 600 L min−1 m−2 | Fluids and inotropes |
Bender et al. [23] 1997, USA | Elective aortic and vascular | PAC; CI ≥ 2.8 L min−1 m−2, 8 ≤ Pcwp ≤ 14 mmHg, SVR ≤ 1100 dyne s cm−5 | Fluids and inotropes |
Benes et al. [24] 2010, Europe | Elective abdominal | FloTrac/Vigileo; CI ≥ 2.5 L min−1 m−2 | Fluids and inotropes |
Bisgaard et al. [25] 2013, Europe | Elective peripheral vascular | Lidco; SV < 10%, DO2 > 600 L min−1 m−2 | Fluids and inotropes |
Brandstrup et al. [26] 2012, Europe | Elective abdominal | Esophageal Doppler SV increase > 10% | Fluids |
Broch et al. [27] 2016, Europe | Major abdominal | Nexfin system; PPV > 10% CI ≥ 2.5 L min−1 m−2 | Fluids and inotropes |
Calvo Vecino et al. [5] 2018, Spain | Major abdominal, urological, gynaecological, or orthopedic surgery | (CardioQ, EDM; SV increase > 10% CI ≥ 2.5 L min−1 m−2 | Fluids and inotropes |
Cecconi et al. [28] 2011, Europe | Orthopaedic | FloTrac/Vigileo; SV < 10%, DO2 > 600 L min−1 m−2 | Fluids and inotropes |
Challand et al. [29] 2013, Europe | Major abdominal | Esophageal Doppler SV increase of 10% | Fluids |
Colantonio et al. [30] 2015, Europe | Cytoreductive surgery | FloTrac/Vigileo; CI ≥ 2.5 L min−1 m−2 SVI > 35 ml∙min−1∙m−2 | Fluids and inotropes |
Correa-Gallego et al. [31] 2015, Europe | Elective liver resection | FloTrac/Vigileo; SVV < 2 DS of pre-induction | Fluids |
Elgendy et al. [32] 2017, Africa | Major abdominal | FloTrac/Vigileo; SVV < 12%, CI ≥ 2.5 L min−1 m−2 | Fluids and inotropes |
Forget et al. [33] 2011, Europe | Major abdominal | Masimo set pulse oxymeter; PVI < 13% | Fluids |
Gomez-Izquierdo et al. [34] 2017, Canada | Colorectal surgery | Cardio Q rise of SV > 10% | Fluids |
Jammer et al. [35] 2010, Europe | Colo-rectal surgery | CVC ScVO2 > 75% | Fluids |
Jhanii et al. [36] 2010, Europe | Elective gastro-intestinal | Not stated rise of SV > 10% | Fluids and inotropes |
Joosten et al. [37] 2019, Europe | Major abdomina | Clearsight closed loop; SVV > 13%, CI 2.5 3 L min−1 m−2 | Fluids |
Kaufmann et al. [38] 2018, Europe | Orthopaedic | Esophageal Doppler rise of SV > 10% CI ≥ 2.5 L min−1 m−2 | Fluids and inotropes |
Kumar et al. [39] 2016, India | Elective abdominal | FloTrac/Vigileo; SVV < 10%, | Fluids and inotropes |
Lobo et al. [40] 2000, Brazil | Elective major abdominal or vascular | PAC; DO2 > 600 mL min−1 m−2 | Fluids and inotropes |
Lopes et al. [41] 2007, Brazil | Elective abdominal | Radial artery line; ΔPP ≤ 10% | Fluids |
Luo et al. [42] 2017, China | Neurosurgery | FloTrac/Vigileo; SVV < 15%, CI ≥ 2.5 L min−1 m−2 | Fluids and inotropes |
Mayer et al. [43] 2010, Europe | Major abdominal | FloTrac/Vigileo; CI ≥ 2.5 L min−1 m−2 | Fluids and inotropes |
Mikor et al. [44] 2015, Europe | Major abdominal | Cevox ScVO2 > 75% or reduction 3% | Fluids and inotropes |
Moppett et al. [45] 2014, Europe | Emergent orthopaedic | LiDCO; SV increase < 10% | Fluids |
Mukai et al. [46] 2020, Japan | Tranthoracic eophageal resection | FloTrac/Vigileo; SVV < 12%, | Fluids and inotropes |
Noblett et al. [47] 2005, Europe | Major abdominal | Esophageal Doppler; SV optimization | Fluids |
Pearse et al. [48] 2005, Europe | Elective or emergent major general | LiDCO; DO2 > 600 mL min−1 m−2, SV > 10% | Fluids and inotropes |
Pearse et al. [49] 2014, Europe | Major general | LiDCO; SV increase < 10% | Fluids and inotropes |
Pestana et al. [50] 2014, multicentric | Major abdominal | NICOM; CI ≥ 2.5 L min−1 m−2 | Fluids and inotropes |
Pillai et al. [51] 2011 USA | Radical cystectomy | Cardio Q increase of SV > 10% | Fluids |
Salzwedel et al. [52] 2013, Europe | Major abdominal | ProAQT PPV > 10% CI ≥ 2.5 L/min/m2 | Fluids and inotropes |
Schereen et al. [53] 2013, Europe | Major abdominal and urologic | FloTrac/Vigileo; SVV < 10% | Fluids |
Schmid et al. [54] 2019, Europe | Orthopaedic | PulsioFlex SVI increase < 10% CI ≥ 2.5 L/min/m2 | Fluids and inotropes |
Shoemaker et al. [55] 1998, USA | Emergent or elective major abdominal (general or vascular) | PAC; CI > 4.5 L min−1 m−2, DO2 > 600 mL min−1 m2, VO2 > 170 mL min−1 m−2 | Fluids and inotropes |
Sinclair et al. [56] 1997, Europe | Orthopaedic | Esophageal Doppler SV optimization with FTc between 0.35–0.4 s | Fluids |
Srinvasa et al. [57] 2012, Australia | Elective colectomy | Esophageal Doppler SV optimization with FTc between 0.35–0.4 s | Fluids |
Stens et al. [58] 2017, Europe | Major abdominal | Nexfin device PPV < 12% CI > 2.5 L min−1 m−2 | Fluids and inotropes |
Szturz et al. [59] 2019, Europe | Major abdominal | Esophageal Doppler FTc < 330 ms CI > 2.5 L min−1 m−2 | Fluids and inotropes |
Ueno et al. [60] 1998, China | Hepatic resection | PAC; CI > 4.5 L min−1 m−2, DO2 > 600 mL min−1 m2, VO2 > 170 mL min−1 m−2 | Fluids and inotropes |
Van Beest [61] 2014, Europe | Elective major | In spectra system StO2 > 80% | Fluids and inotropes |
Venn et al. [62] 2002, Europe | Orthopaedic | Esophageal Doppler SV optimization with FTc > 0.4 s | Fluids |
Wakeling et al. [63] 2005, Europe | Elective major bowel | Esophageal Doppler; SV optimization and rise in CVP < 3 mmHg | Fluids |
Weineberg et al. [64] 2017, Australia | Pancreaticoduodenectomy | FloTrac/Vigileo; SVV < 20% baseline CI ≥ 2 L min−1 m−2 | Fluids and inotropes |
Weineberg et al. [65] 2019, Australia | Liver resection | FloTrac/Vigileo; SVV< 20% baseline CI ≥ 2.2 L min−1 m−2 | Fluids and inotropes |
Wilson et al. [66] 1999, Europe | Elective major (abdominal, vascular, urologic) | PAC; DO2 > 600 mL min−1 m−2 | Fluids and inotropes |
Wu et al. [67] 2017, China | Neurosurgery | FloTrac/Vigileo; SVV < 12%, CI > 2.5 L min−1 m−2 | Fluids and inotropes |
Zhang et al. [68] 2013, China | Thorascopic lobectomy | FloTrac/Vigileo; SVV < 10%, CI > 2.5 L min−1 m−2 | Fluids and inotropes |
Zheng et al. [69] 2013, China | Elective abdominal | FloTrac/Vigileo; SVI > 35 mL/m2, CI ≥ 2.5 L min−1 m−2 | Fluids and inotropes |